Abstract
Eosinophils are multifunctional, evolutionary conserved leukocytes that are involved in a plethora of responses ranging from regulation of tissue homeostasis, host defense and cancer. Although eosinophils have been studied mostly in the context of Type 2 inflammatory responses, it is now evident that they participate in Type 1 inflammatory responses and can respond to Type 1 cytokines such as IFN-γ. Notably, both Type 1- and Type 2 inflammatory environments are characterized by tissue damage and cell death. Collectively, this raises the possibility that eosinophils can interact with apoptotic cells, which can alter eosinophil activation in the inflammatory milieu. Herein, we demonstrate that eosinophils can bind and engulf apoptotic cells. We further show that exposure of eosinophils to apoptotic cells induces marked transcriptional changes in eosinophils, which polarize eosinophils towards an anti-inflammatory phenotype that is associated with wound healing and cell migration. Using an unbiased RNA sequencing approach, we demonstrate that apoptotic cells suppress the inflammatory responses of eosinophils that were activated with IFN-γ + E. coli (e.g., Type 1 eosinophils) and augment IL-4-induced eosinophil activation (e.g., Type 2 eosinophils). These data contribute to the growing understanding regarding the heterogeneity of eosinophil activation patterns and highlight apoptotic cells as potential regulators of eosinophil polarization.
Original language | English |
---|---|
Article number | 1041660 |
Journal | Frontiers in Immunology |
Volume | 13 |
DOIs | |
State | Published - 31 Oct 2022 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:Copyright © 2022 Dolitzky, Hazut, Avlas, Grisaru-Tal, Itan, Zaffran, Levi-Schaffer, Gerlic and Munitz.
Funding
This work was supported by grants and fellowships to MA from the US-Israel Bi-national Science Foundation (grant no. 2015163), Israel Science Foundation (grants no. 886/15 and 542/20), Israel Cancer Research Fund, Richard Eimert Research Fund on Solid Tumors, Israel Cancer Association, Dotan Hemato Oncology Fund, Cancer Biology Research Center, Tel Aviv University, The Tel Aviv University Faculty of Medicine Recanati Fund, and Azrieli Foundation Canada-Israel, and in part by grants to Francesca Levi-Schaffer from the US-Israel Bi-national Science Foundation (grant no 2015045.) and Aimwell Charitable Trust (UK).
Funders | Funder number |
---|---|
Azrieli Foundation Canada-Israel | 2015045 |
Cancer Biology Research Center | |
Dotan Hemato Oncology Fund | |
Richard Eimert Research Fund on Solid Tumors | |
US-Israel bi-national Science Foundation | 2015163 |
Israel Cancer Research Fund | |
United States - Israel Binational Science Foundation | |
Israel Cancer Association | |
Israel Science Foundation | 886/15, 542/20 |
Tel Aviv University | |
Azrieli Foundation |
Keywords
- IFN-gamma
- IL-4
- allergy
- apoptotic cells
- eosinophils
- inflammation